ZA963211B - Chromone derivatives - Google Patents

Chromone derivatives

Info

Publication number: ZA963211B
Authority: ZA; South Africa
Prior art keywords: chromone derivatives; chromone; derivatives
Prior art date: 1995-04-24

Application number

ZA963211A

Other languages

English (en)

Inventor

Andreas Von Sprecher

Marc Gerspacher

Robert Mah

Silvio Roggo

Walter Schilling

Silvio Ofner

Siem Jacob Veenstra

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-24

Filing date

1996-04-23

Publication date

1996-10-24

1996-04-23 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1996-10-24 Publication of ZA963211B publication Critical patent/ZA963211B/xx

Links

150000004777 chromones Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

ZA963211A 1995-04-24 1996-04-23 Chromone derivatives ZA963211B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH115795		1995-04-24

Publications (1)

Publication Number	Publication Date
ZA963211B true ZA963211B (en)	1996-10-24

Family

ID=4203819

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA963211A ZA963211B (en)	1995-04-24	1996-04-23	Chromone derivatives

Country Status (21)

Country	Link
US (1)	US5604247A (fr)
EP (1)	EP0739892B1 (fr)
JP (1)	JP3068458B2 (fr)
KR (1)	KR100416674B1 (fr)
CN (1)	CN1063176C (fr)
AR (1)	AR001813A1 (fr)
AT (1)	ATE224891T1 (fr)
AU (1)	AU714523B2 (fr)
BR (1)	BR9602025A (fr)
CA (1)	CA2174707C (fr)
DE (1)	DE59609707D1 (fr)
DK (1)	DK0739892T3 (fr)
ES (1)	ES2183923T3 (fr)
HU (1)	HUP9601062A3 (fr)
IL (1)	IL117989A (fr)
NO (1)	NO309813B1 (fr)
NZ (1)	NZ286422A (fr)
PT (1)	PT739892E (fr)
RU (1)	RU2156250C2 (fr)
TW (1)	TW475930B (fr)
ZA (1)	ZA963211B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0912178A4 (fr) *	1996-05-24	2000-08-16	Lilly Co Eli	Methodes de traitement de l'hypertension
TW426667B (en) *	1997-11-19	2001-03-21	Pfizer	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
WO2000010545A2 (fr) *	1998-08-25	2000-03-02	Novartis Ag	Utilisations pharmaceutiques
IL145949A0 (en) *	1999-05-21	2002-07-25	Pfizer Prod Inc	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
GB0220953D0 (en)	2002-09-10	2002-10-23	Novartis Ag	Organic compounds
GB2394417A (en) *	2002-10-24	2004-04-28	Novartis Ag	Solid dispersion comprising a piperidine substance P antagonist and a carrier
DE10256174A1 (de) *	2002-12-02	2004-06-09	Merck Patent Gmbh	2-Benzoylchromonderivate
DE10256182A1 (de) *	2002-12-02	2004-06-24	Merck Patent Gmbh	2-Oxadiazolchromonderivate
US20050209274A1 (en) *	2004-02-26	2005-09-22	Lynch John K	Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
CN1300163C (zh) *	2004-06-23	2007-02-14	南京大学	3－羟基色原酮糖苷及其制法和用途
AU2007238071B2 (en) *	2006-04-18	2012-06-07	Abbvie Inc.	Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
GB0701365D0 (en) *	2007-01-24	2007-03-07	Glaxo Group Ltd	Novel pharmaceutical compositions
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2189027B1 (fr) *	1972-06-21	1976-03-05	Leurquin Laboratoires Fr
FR2376145A1 (fr) *	1977-01-03	1978-07-28	Thea Therapeutiques Applic Sa	Nouveaux derives de chromones a activite medicamenteuse et leur preparation
DE3117389A1 (de) *	1981-05-02	1982-11-18	Boehringer Mannheim Gmbh, 6800 Mannheim	Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2593504B1 (fr) *	1986-01-30	1988-12-09	Ile De France	Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
FR2673629B1 (fr) *	1991-03-08	1993-05-07	Adir	Nouveaux derives du benzopyrane leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
MY110227A (en) *	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
WO1995011895A1 (fr) *	1993-10-26	1995-05-04	Ciba-Geigy Ag	N-benzoyl-4-oxy/thio-piperidines a substitution en position utilisees comme antagonistes du recepteur de la substance p
CA2198382A1 (fr) *	1994-09-30	1996-04-11	Novartis Ag	Composes 1-acyl-4-aliphatylaminopiperidine
TW397825B (en) *	1994-10-14	2000-07-11	Novartis Ag	Aroyl-piperidine derivatives

1996
- 1996-04-11 RU RU96107121/04A patent/RU2156250C2/ru not_active IP Right Cessation
- 1996-04-11 TW TW085104270A patent/TW475930B/zh not_active IP Right Cessation
- 1996-04-16 US US08/632,971 patent/US5604247A/en not_active Expired - Lifetime
- 1996-04-16 PT PT96810237T patent/PT739892E/pt unknown
- 1996-04-16 ES ES96810237T patent/ES2183923T3/es not_active Expired - Lifetime
- 1996-04-16 DK DK96810237T patent/DK0739892T3/da active
- 1996-04-16 DE DE59609707T patent/DE59609707D1/de not_active Expired - Lifetime
- 1996-04-16 AT AT96810237T patent/ATE224891T1/de not_active IP Right Cessation
- 1996-04-16 EP EP96810237A patent/EP0739892B1/fr not_active Expired - Lifetime
- 1996-04-21 IL IL11798996A patent/IL117989A/xx active IP Right Grant
- 1996-04-22 AU AU50805/96A patent/AU714523B2/en not_active Ceased
- 1996-04-22 NZ NZ286422A patent/NZ286422A/en unknown
- 1996-04-22 CA CA002174707A patent/CA2174707C/fr not_active Expired - Fee Related
- 1996-04-23 ZA ZA963211A patent/ZA963211B/xx unknown
- 1996-04-23 JP JP8101568A patent/JP3068458B2/ja not_active Expired - Fee Related
- 1996-04-23 CN CN96106111A patent/CN1063176C/zh not_active Expired - Fee Related
- 1996-04-23 KR KR1019960012355A patent/KR100416674B1/ko not_active Expired - Fee Related
- 1996-04-23 HU HU9601062A patent/HUP9601062A3/hu unknown
- 1996-04-23 NO NO961616A patent/NO309813B1/no unknown
- 1996-04-24 AR AR33626596A patent/AR001813A1/es unknown
- 1996-04-24 BR BR9602025A patent/BR9602025A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2174707A1 (fr)	1996-10-25
KR100416674B1 (ko)	2004-06-11
NO961616D0 (no)	1996-04-23
IL117989A0 (en)	1996-08-04
IL117989A (en)	2000-01-31
EP0739892B1 (fr)	2002-09-25
CN1063176C (zh)	2001-03-14
JPH093066A (ja)	1997-01-07
EP0739892A3 (fr)	1997-01-22
AU714523B2 (en)	2000-01-06
HUP9601062A3 (en)	1998-10-28
DE59609707D1 (de)	2002-10-31
RU2156250C2 (ru)	2000-09-20
TW475930B (en)	2002-02-11
MX9601515A (es)	1997-09-30
PT739892E (pt)	2003-01-31
JP3068458B2 (ja)	2000-07-24
ES2183923T3 (es)	2003-04-01
NO961616L (no)	1996-10-25
ATE224891T1 (de)	2002-10-15
HUP9601062A2 (en)	1997-10-28
NZ286422A (en)	1998-01-26
AU5080596A (en)	1996-11-07
CA2174707C (fr)	2008-03-25
NO309813B1 (no)	2001-04-02
KR960037680A (ko)	1996-11-19
CN1141921A (zh)	1997-02-05
DK0739892T3 (da)	2003-01-20
AR001813A1 (es)	1997-12-10
EP0739892A2 (fr)	1996-10-30
US5604247A (en)	1997-02-18
HU9601062D0 (en)	1996-06-28
BR9602025A (pt)	1998-10-06

Publication	Publication Date	Title
NZ305444A (en)	1999-03-29	4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en)	2003-05-29	5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en)	2001-05-20	Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en)	1997-05-28	Glucoxide derivatives
ZA969990B (en)	1997-07-08	Oxymethoxy-3-aryl-pyrone derivatives
ZA96228B (en)	1996-07-26	Indolepiperidine derivatives
SG64953A1 (en)	1999-05-25	Purin-6-one derivatives
HU9600876D0 (en)	1996-05-28	Benzonitril- and -fluoride derivatives
NZ332395A (en)	1999-02-25	Benzonthiazole derivatives
HUP9600107A2 (en)	1997-05-28	9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
HUP9900672A3 (en)	2001-11-28	Pyrroloazepine derivatives
SI0758644T1 (en)	2004-04-30	Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
HU9601062D0 (en)	1996-06-28	Chromone derivatives
SG60005A1 (en)	1999-02-22	1-Fluorocyclohexene-difluorophenyl derivatives
IL123621A0 (en)	1998-10-30	Diarylalkenylamine derivatives
GR3035577T3 (en)	2001-06-29	Benzisothiazolyl-substituted aminomethylchroman derivatives
ZA964470B (en)	1996-12-11	Cycloalkane-benzylidene derivatives
IL117858A0 (en)	1996-08-04	4-Indolypiperazinyl derivatives
ZA96629B (en)	1996-10-24	4-Aminobenzolylguanidine derivatives
GR3030132T3 (en)	1999-07-30	Chromane derivatives
HU9602324D0 (en)	1996-10-28	Piperidinyl-methyl-oxazolidinon derivatives
EP0754668A3 (fr)	1997-08-27	Dérivés de l'éther fluoro-benzylique
ZA967204B (en)	1997-03-03	Alkenyl-benzoylguanidine derivatives
GB9516349D0 (en)	1995-10-11	Aza-anthracyclinone derivatives
GR3036344T3 (en)	2001-11-30	4-mercapto-benzoylguanidine derivatives